Optain (Australia)

Optain is a leading international MedTech company specializing in the development of advanced AI software solutions designed to enhance disease screening capabilities. Optain's Eyetelligence Assure software utilizes full-color fundus images to screen for referable eye diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration. Furthermore, the technology extends its capabilities to screen for cardiovascular diseases, providing a comprehensive risk assessment profile. Optain is committed to harnessing the power of AI to deliver affordable clinical support tools, making disease screening accessible anytime, anywhere.

Located in Melbourne, Australia, Optain is dedicated to innovation and excellence in the medical technology field. Optain's primary address is in Melbourne, AU. With a focus on cutting-edge AI and a vision to revolutionize disease screening, Optain is poised to make a significant impact on global healthcare. The company’s commitment to affordability and accessibility ensures that its solutions can benefit a wide range of healthcare providers and patients.

Optain aims to provide certainty in disease detection through its advanced software solutions. As Optain continues to grow and expand its reach, it remains committed to its core mission of improving healthcare outcomes through the power of AI. We invite the manager of Optain to create a customized and exclusive company showcase and product listing on our platform to further highlight the company's innovative solutions and vision.